Published in

Future Medicine, Nanomedicine, 16(11), p. 2083-2101, 2016

DOI: 10.2217/nnm-2016-0100

Links

Tools

Export citation

Search in Google Scholar

The quest for the shortest fragments of A (13–19) and B (12–17) responsible for the aggregation of human insulin

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Aim: To identify the shortest components of A13-A19, B12-B17 fragments capable for fibrillation and to validate the dependability of aggregation on the presence of hydroxyl group engaged in the ‘tyrosine kissing’. Materials & methods: Fragments A13-A19 and B12-B17 of insulin and all shortened analogues were obtained by using DMT/NMM/TosO- as a coupling reagent. The aggregation was studied by three independent tests. Results: Studies on the susceptibility to aggregation of truncated analogs of insulin amyloidogenic core show three groups of peptides. Conclusion: Truncation of A13-A419 fragment shows that fibrous structures are formed by all peptides bearing 13H-LeuTyr-OH14. Propensity to aggregation was found for 16H-TyrLeu-OH17 B12-B17 fragment. Tyrosine residue modification by incorporation of tert-butyl group on hydroxyl function gave analogues still predisposed to aggregation.